BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 14679001)

  • 21. Oncolytic adenovirus CG7870 in combination with radiation demonstrates synergistic enhancements of antitumor efficacy without loss of specificity.
    Dilley J; Reddy S; Ko D; Nguyen N; Rojas G; Working P; Yu DC
    Cancer Gene Ther; 2005 Aug; 12(8):715-22. PubMed ID: 15832172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abrogation of heat shock protein 70 induction as a strategy to increase antileukemia activity of heat shock protein 90 inhibitor 17-allylamino-demethoxy geldanamycin.
    Guo F; Rocha K; Bali P; Pranpat M; Fiskus W; Boyapalle S; Kumaraswamy S; Balasis M; Greedy B; Armitage ES; Lawrence N; Bhalla K
    Cancer Res; 2005 Nov; 65(22):10536-44. PubMed ID: 16288046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamics of spheroid self-assembly in liquid-overlay culture of DU 145 human prostate cancer cells.
    Enmon RM; O'Connor KC; Lacks DJ; Schwartz DK; Dotson RS
    Biotechnol Bioeng; 2001 Mar; 72(6):579-91. PubMed ID: 11460249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth of prostatic cancer cells, DU 145, as multicellular spheroids and effects of estramustine.
    Essand M; Nilsson S; Carlsson J
    Anticancer Res; 1993; 13(5A):1261-8. PubMed ID: 8239495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the Hsp90 inhibitor NVP-AUY922 in multicellular tumour spheroids with respect to effects on growth and PET tracer uptake.
    Monazzam A; Razifar P; Ide S; Rugaard Jensen M; Josephsson R; Blomqvist C; Langström B; Bergström M
    Nucl Med Biol; 2009 Apr; 36(3):335-42. PubMed ID: 19324279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1H-NMR evidence for a different response to the same dose (2 Gy) of ionizing radiation of MG-63 human osteosarcoma cells and three-dimensional spheroids.
    Santini MT; Romano R; Rainaldi G; Ferrante A; Indovina P; Motta A; Indovina PL
    Anticancer Res; 2006; 26(1A):267-81. PubMed ID: 16475707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined effects of radiotherapy and photodynamic therapy on an in vitro human prostate model.
    Colasanti A; Kisslinger A; Quarto M; Riccio P
    Acta Biochim Pol; 2004; 51(4):1039-46. PubMed ID: 15625575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ionizing radiation enhances the therapeutic potential of TRAIL in prostate cancer in vitro and in vivo: Intracellular mechanisms.
    Shankar S; Singh TR; Srivastava RK
    Prostate; 2004 Sep; 61(1):35-49. PubMed ID: 15287092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of radiation response of prostatic carcinoma by taxol: therapeutic potential for late-stage malignancy.
    Lokeshwar BL; Ferrell SM; Block NL
    Anticancer Res; 1995; 15(1):93-8. PubMed ID: 7733649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
    Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of modest dose irradiation in combination with long-term endocrinal treatment for high-risk prostate cancer: a preliminary report.
    Sasaki T; Nakamura K; Shioyama Y; Ohga S; Urashima Y; Terashima H; Koga H; Naito S; Noma H; Komatsu K; Yamaguchi A; Honda H
    Jpn J Clin Oncol; 2004 Jul; 34(7):420-4. PubMed ID: 15342670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined effect of tumor necrosis factor-alpha and ionizing radiation on the induction of apoptosis in 5637 bladder carcinoma cells.
    Baierlein SA; Distel L; Sieber R; Weiss C; Rödel C; Sauer R; Rödel F
    Strahlenther Onkol; 2006 Aug; 182(8):467-72. PubMed ID: 16896593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergism between cisplatin and radiotherapy in an in vitro prostate tumor cell line.
    Geldof AA; Kruit A; Newling DW; Slotman BJ
    Anticancer Res; 1999; 19(1A):505-8. PubMed ID: 10226589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genistein potentiates the radiation effect on prostate carcinoma cells.
    Hillman GG; Forman JD; Kucuk O; Yudelev M; Maughan RL; Rubio J; Layer A; Tekyi-Mensah S; Abrams J; Sarkar FH
    Clin Cancer Res; 2001 Feb; 7(2):382-90. PubMed ID: 11234894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination therapy of insulin-like growth factor binding protein-3 and retinoid X receptor ligands synergize on prostate cancer cell apoptosis in vitro and in vivo.
    Liu B; Lee KW; Li H; Ma L; Lin GL; Chandraratna RA; Cohen P
    Clin Cancer Res; 2005 Jul; 11(13):4851-6. PubMed ID: 16000583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of combined Ad5- delta 24RGD and radiation therapy in in vitro versus in vivo models of malignant glioma.
    Lamfers ML; Idema S; Bosscher L; Heukelom S; Moeniralm S; van der Meulen-Muileman IH; Overmeer RM; van der Valk P; van Beusechem VW; Gerritsen WR; Vandertop WP; Dirven CM
    Clin Cancer Res; 2007 Dec; 13(24):7451-8. PubMed ID: 18094429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The geldanamycin analogue 17-allylamino-17-demethoxygeldanamycin inhibits the growth of GL261 glioma cells in vitro and in vivo.
    Newcomb EW; Lukyanov Y; Schnee T; Esencay M; Fischer I; Hong D; Shao Y; Zagzag D
    Anticancer Drugs; 2007 Sep; 18(8):875-82. PubMed ID: 17667592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overcoming the radioresistance of prostate cancer cells with a novel Bcl-2 inhibitor.
    An J; Chervin AS; Nie A; Ducoff HS; Huang Z
    Oncogene; 2007 Feb; 26(5):652-61. PubMed ID: 16909121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heat shock protein 90 inhibition by 17-allylamino-17- demethoxygeldanamycin: a novel therapeutic approach for treating hormone-refractory prostate cancer.
    Neckers L
    Clin Cancer Res; 2002 May; 8(5):962-6. PubMed ID: 12006507
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of the cassette dosing approach for assessing the pharmacokinetics of geldanamycin analogues in mice.
    Smith NF; Hayes A; Nutley BP; Raynaud FI; Workman P
    Cancer Chemother Pharmacol; 2004 Dec; 54(6):475-86. PubMed ID: 15526201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.